Recent Finacing
Recent Raise
Arctic Therapeutics is an Icelandic–US drug discovery company using applied genomics to develop small-molecule therapeutics, advancing AT-001 (EMA-approved phase IIb/III in HCCAA) and AT-004 (phase IIa planned in acne).
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Arctic Therapeutics.